Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. intraoperative visual
Show results for

Refine by
Date

  • Older

Intraoperative Visual Articles & Analysis

12 news found

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of Wide-Field Optical Coherence Tomography (WF-OCT) in Head and Neck Surgeries

Perimeter Medical Imaging AI Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of Wide-Field Optical Coherence Tomography (WF-OCT) in Head and Neck Surgeries

The study’s findings validate the further exploration of the use of Perimeter’s wide-field Optical Coherence Tomography (WF-OCT) technology to visualize margins during head and neck surgeries. The research study, conducted at Mount Sinai Icahn School of Medicine, included 53 adult patients undergoing primary ablative surgery of the oral cavity or oropharynx for ...

ByPerimeter Medical Imaging AI


Perimeter Medical Imaging AI and Pavilion Surgery Center Announce Placement of Perimeter S-Series OCT for Use at Ambulatory Surgery Center in Orange, CA

Perimeter Medical Imaging AI and Pavilion Surgery Center Announce Placement of Perimeter S-Series OCT for Use at Ambulatory Surgery Center in Orange, CA

We remain laser-focused on bringing Perimeter’s transformative ultra-high resolution medical imaging technology directly into the OR to assist the surgeon with real-time intraoperative margin visualization – with the aim of improving patient outcomes and reducing healthcare ...

ByPerimeter Medical Imaging AI


OnLume Surgical Awarded $2 Million Grant from National Cancer Institute to Advance the Development of its Novel Fluorescence-Guided Surgery Device

OnLume Surgical Awarded $2 Million Grant from National Cancer Institute to Advance the Development of its Novel Fluorescence-Guided Surgery Device

The $2 Million Phase II Small Business Innovation Research (SBIR) grant from the NCI will fund further refinement of OnLume’s FGS imaging device for visualization of critical anatomy, augmenting precision during surgery. OnLume’s imaging device will seamlessly integrate into the clinical workflow with a small physical footprint, an easy-to-use interface and ...

ByOnLume Inc.


Activ Surgical Successfully Completes Institutional Review Board Study at University at Buffalo

Activ Surgical Successfully Completes Institutional Review Board Study at University at Buffalo

Christina Sanders, medical director of ECMC Synergy Bariatrics for UB, and demonstrated how the FDA-cleared ActivSight imaging module can provide real time, on-demand insights and intraoperative visual data and images not currently available to surgeons through existing technologies. ...

ByActiv Surgical, Inc.


Hikma Ventures leads Series B extension in Activ Surgical to support the global commercialization of its platform

Hikma Ventures leads Series B extension in Activ Surgical to support the global commercialization of its platform

It allows surgeons to access critical intraoperative visual data as AR overlays. In 2021, the ActivSight imaging module was cleared by the FDA and successfully used in its first-in-human studies. ...

ByActiv Surgical, Inc.


Activ Surgical Granted Third U.S. Patent for ActivSight™ Imaging Module

Activ Surgical Granted Third U.S. Patent for ActivSight™ Imaging Module

This patent protects our intellectual property that provides intraoperative visual data and images on blood flow and perfusion not currently available to surgeons through existing technologies. ...

ByActiv Surgical, Inc.


How virtually `scrubbing in` could help surgeons hone their skills

How virtually `scrubbing in` could help surgeons hone their skills

There are a slew of digital health startups looking to change the surgical space to make it more connected, from Hillrom's surgical communication tool to Activ Surgical’s solution that gives surgeons real-time intraoperative visual data. London-based virtual surgery platform Proximie is looking to tackle surgical connectivity challenges with its augmented ...

ByProximie Limited


Avelas Makes Senior Appointments and Provides Update on Pegloprastide Phase III Clinical Program

Avelas Makes Senior Appointments and Provides Update on Pegloprastide Phase III Clinical Program

Ambareen Sheriff appointed as Vice President, Regulatory and Quality and Robin Stevens appointed as Non-Executive Director Novel, best-in-class agent for visualizing breast cancer margins to enter Phase III trial in 1H22 SAN DIEGO, CA – Avelas Biosciences, Inc. ...

ByAvelas Biosciences


Alume Biosciences Granted FDA Fast Track Designation of ALM-488 for Surgical Nerve Visualization

Alume Biosciences Granted FDA Fast Track Designation of ALM-488 for Surgical Nerve Visualization

ALM-488 is an investigational fluorescently labelled nerve targeting pharmaceutical being developed as an adjunct for the visualization of nerves at risk for injury during head and neck surgery. ...

ByAlume Biosciences, Inc.


Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use During Breast Cancer Surgery

Avelas Receives FDA Breakthrough Therapy Designation for Pegloprastide (AVB-620) for Use During Breast Cancer Surgery

SAN DIEGO, CA – Avelas Biosciences, Inc., pioneering the field of intraoperative fluorescent cancer imaging, today announced that the company has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for pegloprastide (AVB-620) for the intraoperative detection and visualization of positive margins during ...

ByAvelas Biosciences


FDA clears nView medical’s first imaging system - nView s1

FDA clears nView medical’s first imaging system - nView s1

The technology can be used intraoperatively to visualize the surgery and at the end of the procedure to confirm the quality of the surgery. ...

BynView medical Inc.


Gauss Surgical Announces $12.6 Million Series B Financing

Gauss Surgical Announces $12.6 Million Series B Financing

Annually, the direct cost of over 13 million transfusions exceeds $15 billion.1,2 According to the Society for the Advancement of Blood Management, approximately 88 percent of all transfusions either resulted in harm or showed no benefit to the patient.2 Currently, intraoperative blood loss is visually estimated, which is known to be inaccurate and can result in ...

ByGauss Surgical

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT